Cas:488722-57-2 6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole manufacturer & supplier

We serve Chemical Name:6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole CAS:488722-57-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole

Chemical Name:6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole
CAS.NO:488722-57-2
Synonyms:Benzothiazole, 6-methyl-2-(4-nitrophenyl)-;6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole
Molecular Formula:C14H10N2O2S
Molecular Weight:270.306
HS Code:2934200090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:451.9±47.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.693
PSA:86.95000
Exact Mass:270.046295
LogP:4.68

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzothiazole, 6-methyl-2-(4-nitrophenyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole Use and application,Benzothiazole, 6-methyl-2-(4-nitrophenyl)- technical grade,usp/ep/jp grade.


Related News: Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole manufacturer The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. 6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole supplier The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. 6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole vendor The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. 6-Methyl-2-(4-nitrophenyl)-1,3-benzothiazole factory Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.